These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
642 related items for PubMed ID: 15715745
1. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia. Cook B, Hoogenboom G. Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745 [Abstract] [Full Text] [Related]
2. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature. Zink M, Knopf U, Henn FA, Thome J. Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045 [Abstract] [Full Text] [Related]
3. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report. Croissant B, Hermann D, Olbrich R. Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466 [Abstract] [Full Text] [Related]
4. Management of treatment resistant schizophrenia unresponsive to clozapine. Barnes TR, McEvedy CJ, Nelson HE. Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653 [No Abstract] [Full Text] [Related]
5. Combination of ziprasidone and clozapine in treatment-resistant schizophrenia. Zink M, Mase E, Dressing H. Hum Psychopharmacol; 2004 Jun; 19(4):271-3. PubMed ID: 15181656 [Abstract] [Full Text] [Related]
6. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial. Assion HJ, Reinbold H, Lemanski S, Basilowski M, Juckel G. Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048 [Abstract] [Full Text] [Related]
10. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder. Müller MJ, Eich FX, Regenbogen B, Sachse J, Härtter S, Hiemke C. J Psychopharmacol; 2009 May; 23(3):278-86. PubMed ID: 18562411 [Abstract] [Full Text] [Related]
11. Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study. Kim SW, Shin IS, Kim JM, Yang SJ, Hwang MY, Yoon JS. J Clin Psychopharmacol; 2008 Jun; 28(3):349-52. PubMed ID: 18480697 [No Abstract] [Full Text] [Related]
12. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study. Molina JD, Lerma-Carrillo I, Leonor M, Pascual F, Blasco-Fontecilla H, González-Parra S, López-Muñoz F, Alamo C. Clin Neuropharmacol; 2009 Jun; 32(1):10-5. PubMed ID: 18978498 [Abstract] [Full Text] [Related]
16. THE LESSA (Lebanese Short-term Study with Amisulpride) STUDY a Phase IV clinical trial in acutely ill schizophrenic patients. Baddoura R, Ourgandjian H. J Med Liban; 2004 Jun; 52(2):78-85. PubMed ID: 15884686 [Abstract] [Full Text] [Related]
17. Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study. Genç Y, Taner E, Candansayar S. Adv Ther; 2007 Jun; 24(1):1-13. PubMed ID: 17526456 [Abstract] [Full Text] [Related]
18. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing]. Mercier C, Bret P, Bret MC, Queuille E. Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368 [Abstract] [Full Text] [Related]
19. [Sequence in prescribing neuroleptics: a therapeutic alternative in refractory schizophrenia?]. Allouche G, Joober R, Vanelle JM, Brochier T, Olié JP. Encephale; 1994 Sep; 20(6):777-80. PubMed ID: 7875112 [Abstract] [Full Text] [Related]